Fat and Hidden Liver Cancer
Sailish Honap, Jude A. Oben – 27 February 2021
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: A Patient‐Friendly Summary of the 2019 AASLD Guidelines
Michael L. Volk, Nancy Reau – 27 February 2021
A Case of Rapid Decline in Alcohol‐Associated Liver Disease
Aashesh Verma, Donald Jensen – 27 February 2021
Hepatic Steatosis and Ectopic Fat Are Associated With Differences in Subcutaneous Adipose Tissue Gene Expression in People With HIV
Curtis L. Gabriel, Fei Ye, Run Fan, Sangeeta Nair, James G. Terry, John Jeffrey Carr, Heidi Silver, Paxton Baker, LaToya Hannah, Celestine Wanjalla, Mona Mashayekhi, Sam Bailin, Morgan Lima, Beverly Woodward, Manhal Izzy, Jane F. Ferguson, John R. Koethe – 26 February 2021 – Persons with human immunodeficiency virus (PWH) have subcutaneous adipose tissue (SAT) dysfunction related to antiretroviral therapy and direct viral effects, which may contribute to a higher risk of nonalcoholic fatty liver disease compared with human immunodeficiency virus–negative individuals.
Cancer‐Associated Fibroblasts: Orchestrating the Crosstalk Between Liver Cancer Cells and Neutrophils Through the Cardiotrophin‐Like Cytokine Factor 1–Mediated Chemokine (C‐X‐C motif) Ligand 6/TGF‐β Axis
Martina Mang Leng Lei, Terence Kin Wah Lee – 26 February 2021
Mevalonic Aciduria Associated With Intrahepatic Bile Duct Paucity
Melissa Chiu, Justin Garabon, Lina Chen, Natalya Karp, Akshay Kapoor, Jessica P. Woolfson – 26 February 2021
Recurrent Nodular Regenerative Hyperplasia Following Liver Transplantation in Common Variable Immunodeficiency
Julian Hercun, Esha Parikh, David E. Kleiner, Ivan Fuss, Gulbu Uzel, Warren Strober, Christopher Koh, Steven M. Holland, Theo Heller – 26 February 2021
REPLY:
Alexandre Louvet, Philippe Mathurin – 26 February 2021
Liver‐Specific Deletion of Mouse Tm6sf2 Promotes Steatosis, Fibrosis, and Hepatocellular Cancer
Elizabeth P. Newberry, Zoe Hall, Yan Xie, Elizabeth A. Molitor, Peter O. Bayguinov, Gregory W. Strout, James A.J. Fitzpatrick, Elizabeth M. Brunt, Julian L. Griffin, Nicholas O. Davidson – 26 February 2021
LiverLearning®: Fundamentals of Liver Disease - Hepatitis C 2.0
DESCRIPTION There is currently an anticipated shortage of trained providers capable of diagnosing and treating different liver diseases. As a result of this increased demand and limited specialists in the field, more and more front-line providers are faced with these patients and do not have the experience or resources that will allow them to manage them appropriately.